GHRS: GH Research PLC Stock

by  •  • Comments Off on GHRS: GH Research PLC Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 467.73
Enterprise Value ($M) 377.67
Book Value ($M) 189.37
Book Value / Share 3.64
Price / Book 2.47
NCAV ($M) 144.70
NCAV / Share 2.78
Price / NCAV 3.23

Profitability (mra)
Return on Invested Capital (ROIC) -0.22
Return on Assets (ROA) -0.18
Return on Equity (ROE) -0.19

Liquidity (mrq)
Quick Ratio 15.83
Current Ratio 15.83

Balance Sheet (mrq) ($M)
Current Assets 154.95
Assets 199.61
Liabilities 10.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Lynx1 Capital Management LP 8.10 40.14
11-14 13G/A Ra Capital Management, L.p. 12.90 19.68
02-14 13G Rtw Investments, Lp 6.40
02-14 13G/A Biotechnology Value Fund L P 19.99 12.13
02-14 13G/A Venrock Healthcare Capital Partners II, L.P. 2.50 -62.52
02-09 13G/A Fmr Llc 6.03 -29.60

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-22 9,368 79,985 11.71
2025-01-21 19,361 106,648 18.15
2025-01-17 10,097 60,368 16.73

(click for more detail)

Similar Companies
FOLD – Amicus Therapeutics, Inc. FULC – Fulcrum Therapeutics, Inc.
GANX – Gain Therapeutics, Inc. HCWB – HCW Biologics Inc.
HRMY – Harmony Biosciences Holdings, Inc.


Financial data and stock pages provided by
Fintel.io